Skip to Content

Uncategorized Document

Opportunity for Exclusive or Non-Exclusive Licensing: Prostratin, a Novel Anti-viral Compound Useful in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Visit or use the printed Federal Register if you need an official format.

The full text of this document is currently only available in a basic text format.